Drawing for NADAL

USPTO serial 79296387

NADAL

Reviewed by CopyMark Law Group

Status 603
Filing date
Status date
Registration date
—
Examiner
SETTLES LEWIS, SHAILA E
Law office
TMO LAW OFFICE 114 - EXAMINING ATTORNEY ASSIGNED

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with NADAL?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

CHRISTOPHER J VOCI

CHRISTOPHER J VOCI SIMMONS PERRINE MOYER BERGMAN PLC1150 5TH STREET, SUITE 170CORALVILLE, IA 52241UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005Diagnostic and analysis agents, preparations and reagents for medical and veterinary purposes, namely, for testing of allergies, autoimmunity diseases, presence of bacteria, diabetes, blood glucose levels, inflammation, fertility or infertility, pregnancy, sexually transmitted diseases, urinary tract infections, cancer, hormonal disorders, immune status, presence of fungi, presence of viral markers, infectious diseases, food intolerances, kidney dysfunction, liver dysfunction, thyroid gland dysfunction, cardiovascular dysfunction, or metabolic dysfunction; test strips for medical and veterinary purposes for testing the presence of allergies, autoimmunity markers, bacteria, fungi, viral markers, diabetes markers, inflammation markers, fertility hormones, pregnancy hormones, fertility markers, markers for sexually transmitted diseases, markers for urinary tract infections, markers for infectious diseases, endocrinology markers, metabolic markers, tumor markers, hormones, blood markers, markers for food intolerances, markers for kidney dysfunction, markers for liver dysfunction, markers for thyroid gland dysfunction, markers for cardiovascular dysfunction or markers for metabolic dysfunction, for testing immune status, urine, or blood glucose levels; immunological quick tests for instant diagnostics; medical diagnostic preparations, in particular diagnostic quick tests, for use in the fields of infectology, pediatrics, gynecology, bacteriology, urology, latex agglutination, cardiology, oncology and drug analysis; reagents for use in diagnostic pregnancy tests; reagents for use in ovulation tests for medical purposes; reagents for use in diagnostic HIV tests; reagents for use in drug tests for medical purposes; myocardial infarction markers; diagnostic agents and preparations in the nature of test stripes, test cassettes, multi-line tests, test liquids, ELISA tests, EIAs (enzyme immuno assays), or dry chemistry assay kits for detecting infectious diseasesACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jun 19, 2023FINTFINAL DECISION TRANSACTION PROCESSED BY IB—
Jun 1, 2023FICSFINAL DISPOSITION NOTICE SENT TO IB—
Jun 1, 2023FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Jun 1, 2022MAB3ABANDONMENT NOTICE MAILED - AFTER EX PARTE APPEAL—
Jun 1, 2022MAB3ABANDONMENT NOTICE MAILED - AFTER EX PARTE APPEAL—
Jun 1, 2022ABN3ABANDONMENT - AFTER EX PARTE APPEAL—
Jun 1, 2022EXPTEXPARTE APPEAL TERMINATED—
Apr 19, 2022EXFBEXPARTE APPEAL DISMISSED - FAILURE TO FILE BRIEF—
Apr 17, 2022OPNXNOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB—
Mar 27, 2022OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Mar 23, 2022OPNRNOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB—
Feb 1, 2022GEA1NOTIFICATION OF ACTION DENYING REQ FOR RECON E-MAILED—
Feb 1, 2022GECDACTION DENYING REQ FOR RECON E-MAILED—
Feb 1, 2022CNCFACTION CONTINUING FINAL - COMPLETED—
Jan 7, 2022TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jan 7, 2022CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jan 6, 2022ALIEASSIGNED TO LIE—
Jan 4, 2022ERFRTEAS REQUEST FOR RECONSIDERATION RECEIVED—
Jan 4, 2022EXPIEX PARTE APPEAL-INSTITUTED—
Jan 4, 2022JURTJURISDICTION RESTORED TO EXAMINING ATTORNEY—
Jan 4, 2022EXAFEXPARTE APPEAL RECEIVED AT TTAB—
Jul 21, 2021GNFNNOTIFICATION OF FINAL REFUSAL EMAILED—
Jul 21, 2021GNFRFINAL REFUSAL E-MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Jul 21, 2021CNFRFINAL REFUSAL WRITTENA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Jun 8, 2021TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jun 8, 2021CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jun 8, 2021TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Dec 27, 2020RFNTREFUSAL PROCESSED BY IB—
Dec 9, 2020RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Dec 9, 2020RFRRREFUSAL PROCESSED BY MPU—
Nov 21, 2020RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Nov 20, 2020CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Nov 16, 2020DOCKASSIGNED TO EXAMINER—
Oct 30, 2020MAFRAPPLICATION FILING RECEIPT MAILED—
Oct 26, 2020NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Oct 22, 2020REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance